International Rx Price Study To Be Used In Negotiations With Developed Countries
This article was originally published in The Pink Sheet Daily
Executive Summary
Study mandated by Medicare Rx law could be used to convince developed countries of the need to reduce price controls, Commerce Department official tells Senate subcommittees.
You may also be interested in...
Global Price Control Elimination May Not Affect U.S. Rx Costs, Economist Tells ITA Panel
Payoff from elimination of price controls would be enhanced innovation, not lower costs in U.S., panelists tell Commerce Department hearing. International Rx pricing study is due Sept. 8.
Global Price Control Elimination May Not Affect U.S. Rx Costs, Economist Tells ITA Panel
Payoff from elimination of price controls would be enhanced innovation, not lower costs in U.S., panelists tell Commerce Department hearing. International Rx pricing study is due Sept. 8.
Drug Pricing Practices In Canada, Germany May Stifle Innovation – USTR Report
The U.S. Trade Representative cites Canadian procedures that allow "infringing" generic drugs on the market in adding the country to its IP "watch list." The report expresses concern about Germany's development of a reference pricing system, which would lump brands with generics.